InsurTech Growth Investors & VC Firms
181 firms in this list, with a median first check of $2M. 69 of them lead rounds. Generated from verified public data and updated continuously.
Olympus Partners
StamfordGrowth$75M – $500M
27 people
American Family Ventures
BostonSeed–Growth$250K – $10M
22 people
RedBird Capital Partners
New YorkSeed–Late Stage
25 people
Northlane Capital Partners
BethesdaGrowth$25M – $150M
29 people
TLcom Capital
NairobiSeed–Growth$500K – $10M
31 people
IDC Ventures
MiamiPre-Seed–Growth
42 people
Rakuten Capital
TokyoSeed–Late Stage
21 people
Odyssey Investment Partners
New YorkGrowth–Late Stage$100M – $300M
26 people
World Innovation Lab
Palo AltoGrowth–Late Stage
30 people
Karista
ParisPre-Seed–Growth$324K – $5.4M
12 people
Souter Investments
EdinburghGrowth–Late Stage$2.5M – $38M
13 people
Aquiline Technology Growth
New YorkGrowth
6 people
Echo Health Ventures
PortlandSeed–Growth
25 people
Gallatin Point Capital
GreenwichSeed–Growth$50M – $200M
24 people
2050
ParisSeed–Growth
29 people
RET Ventures
Park CitySeed–Growth
18 people
Jerusalem Venture Partners (JVP)
JerusalemSeed–Growth$1M – $5M
24 people
SC Ventures
SingaporeSeed–Growth
21 people
Iron Pillar
BangaloreGrowth
27 people
Remgro / Invenfin ecosystem
StellenboschSeed–Growth
21 people
Elevar Equity
BengaluruPre-Seed–Growth$1M – $10M
18 people
Next Gear Ventures
Tel AvivPre-Seed–Growth
15 people
New Capital Partners
BirminghamGrowth$5M – $100M
10 people
Finch Capital
AmsterdamSeries A–Growth$5.4M – $16.2M
13 people
Related lists
Growth Investors & VC Firms (4301)Growth Investors & VC Firms in North America (2155)Growth Investors & VC Firms in United States (1870)Growth Investors & VC Firms in Europe (1648)Growth Investors & VC Firms in Global (1397)Healthtech Growth Investors & VC Firms (1282)Growth Investors & VC Firms in Asia-Pacific (1264)Enterprise Software Growth Investors & VC Firms (1211)SaaS Growth Investors & VC Firms (1192)Fintech Growth Investors & VC Firms (1183)
Data sourced from public filings and firms' own websites — see our methodology.









































































































